TXNIP and acute myeloid leukemia: As shown in Fig. 6, combinatorial WWP1 and TXNIP siRNA delivery to AML cells rescued the siRNA WWP1‐induced defects in glucose uptake and glycolysis (Fig. 6G,H and Fig. S3F,G).